Skip to main content

ADVERTISEMENT

breast cancer

Original Research
11/10/2022
This study aims to use the noninvasive MyotonPRO Device to detect differences in biomechanical skin characteristics in patients with breast cancer–related lymphedema.
This study aims to use the noninvasive MyotonPRO Device to detect differences in biomechanical skin characteristics in patients with breast cancer–related lymphedema.
This study aims to use the...
11/10/2022
ePlasty
Review
11/02/2022
This meta-analysis evaluates the outcomes of common surgical treatments of lymphedema and provides suggestions for future research directions. The findings indicate that lymphaticovenous anastomosis is neither superior nor inferior to...
This meta-analysis evaluates the outcomes of common surgical treatments of lymphedema and provides suggestions for future research directions. The findings indicate that lymphaticovenous anastomosis is neither superior nor inferior to...
This meta-analysis evaluates the...
11/02/2022
ePlasty
Pearls for Practice
10/04/2021
Three case reports in the hospital-based outpatient wound care setting demonstrate how a hypochlorous acid–preserved wound cleanser was used, synergistically with other wound care modalities, to achieve a significant reduction in wound...
Three case reports in the hospital-based outpatient wound care setting demonstrate how a hypochlorous acid–preserved wound cleanser was used, synergistically with other wound care modalities, to achieve a significant reduction in wound...
Three case reports in the...
10/04/2021
Wound Management & Prevention
Evidence Corner
10/01/2021
Laura Bolton
This Evidence Corner, which includes 2 studies, clarifies evidence supporting the use of recognized preoperative antibiotic administration to support host defenses in patients undergoing breast cancer surgery.
This Evidence Corner, which includes 2 studies, clarifies evidence supporting the use of recognized preoperative antibiotic administration to support host defenses in patients undergoing breast cancer surgery.
This Evidence Corner, which...
10/01/2021
Wounds
News
08/24/2021
Adjuvant celecoxib offered no disease-free survival benefit compared to placebo in patients with unselected ERBB2-negative primary breast cancer.
Adjuvant celecoxib offered no disease-free survival benefit compared to placebo in patients with unselected ERBB2-negative primary breast cancer.
Adjuvant celecoxib offered no...
08/24/2021
Oncology
Anthony Lucci, MD, The University of Texas MD Anderson Cancer Center
Videos
08/16/2021
Anthony Lucci, MD, highlights 5 developments in breast cancer care he believes we will see come to fruition within the next 5 years.
Anthony Lucci, MD, highlights 5 developments in breast cancer care he believes we will see come to fruition within the next 5 years.
Anthony Lucci, MD, highlights 5...
08/16/2021
Oncology
The use of acellular dermal matrices (ADMs) in extremity reconstruction often involve two-stage reconstruction. Two-stage procedures are generally conducted on patients with large defects...
11/23/2020